Pei Pei
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics
Papers in
-
- Nanoplatforms for cancer theranostics 27
- Oncology 22
- Cancer Immunotherapy and Biomarkers 10
- Co-authors
- Kai Yang (31 shared papers)Teng Liu (19 shared papers)Lin Hu (14 shared papers)Xianzhu Yang (3 shared papers)Erik Kjeang (6 shared papers)Haisheng Qian (4 shared papers)Zhuang Liu (2 shared papers)Wanni Wang (3 shared papers)
- Journals
- Journal of Controlled Release (6 papers)Biomaterials (5 papers)BioResources (5 papers)International Journal of Hydrogen Energy (4 papers)ACS Nano (4 papers)
- Partner nations
- ChinaCanadaUnited Kingdom
In The Last Decade
Pei Pei
116 papers receiving 3.2k citations
Pei Pei's Hit Papers
Peers
Comparison fields: 5 of 159
- Biomaterials 400
- Biomedical Engineering 1.2k
- Immunology 476
- Biotechnology 174
- Cancer Research 260
Countries citing papers authored by Pei Pei
This map shows the geographic impact of Pei Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei Pei more than expected).
Fields of papers citing papers by Pei Pei
This network shows the impact of papers produced by Pei Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei Pei. The network helps show where Pei Pei may publish in the future.
Co-authors
The 25 scholars most cited alongside Pei Pei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 120 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy Hit paper breakdown → | 2020 | 459 |
| 2 | Arsenic induces pancreatic dysfunction and ferroptosis via mitochondrial ROS-autophagy-lysosomal pathway Hit paper breakdown → | 2019 | 307 |
| 3 | 2018 | 176 | |
| 4 | 2020 | 133 | |
| 5 | A Polymeric Hydrogel to Eliminate Programmed Death-Ligand 1 for Enhanced Tumor Radio-Immunotherapy Hit paper breakdown → | 2023 | 122 |
| 6 | 2020 | 118 | |
| 7 | 2019 | 90 | |
| 8 | 2015 | 64 | |
| 9 | 2023 | 61 | |
| 10 | 2019 | 60 | |
| 11 | 2022 | 56 | |
| 12 | 2020 | 53 | |
| 13 | 2018 | 51 | |
| 14 | 2021 | 48 | |
| 15 | 2024 | 44 | |
| 16 | 2022 | 42 | |
| 17 | 2022 | 40 | |
| 18 | 2012 | 40 | |
| 19 | 2021 | 38 | |
| 20 | 2023 | 37 |
About Pei Pei
Pei Pei is a scholar working on Biomedical Engineering, Oncology, Materials Chemistry, Molecular Biology and Immunology, having authored 120 papers that have together received 3.2k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (27 papers), Cancer Immunotherapy and Biomarkers (10 papers), Cancer Research and Treatments (10 papers), Hydrogen Storage and Materials (9 papers), Folate and B Vitamins Research (9 papers), Acupuncture Treatment Research Studies (7 papers), Advanced Nanomaterials in Catalysis (7 papers) and Nanoparticle-Based Drug Delivery (6 papers). The work is most often cited by research in Biomaterials (400 citations), Biomedical Engineering (1.2k citations), Immunology (476 citations), Biotechnology (174 citations) and Cancer Research (260 citations). Pei Pei has collaborated with scholars based in China, Canada and United Kingdom. Frequent co-authors include Kai Yang, Teng Liu, Lin Hu, Xianzhu Yang, Erik Kjeang, Haisheng Qian, Zhuang Liu, Wanni Wang, Zhengbao Zha and Wenhao Shen. Their work appears in journals such as Journal of Controlled Release, Biomaterials, BioResources, International Journal of Hydrogen Energy and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.